70 related articles for article (PubMed ID: 26228224)
21. Adventitial vasa vasorum heterogeneity among different vascular beds.
Galili O; Herrmann J; Woodrum J; Sattler KJ; Lerman LO; Lerman A
J Vasc Surg; 2004 Sep; 40(3):529-35. PubMed ID: 15337884
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of coronary adventitial vasa vasorum using 3D optical coherence tomography--animal and human studies.
Aoki T; Rodriguez-Porcel M; Matsuo Y; Cassar A; Kwon TG; Franchi F; Gulati R; Kushwaha SS; Lennon RJ; Lerman LO; Ritman EL; Lerman A
Atherosclerosis; 2015 Mar; 239(1):203-8. PubMed ID: 25618027
[TBL] [Abstract][Full Text] [Related]
23. Pericyte-specific deletion of ninjurin-1 induces fragile vasa vasorum formation and enhances intimal hyperplasia of injured vasculature.
Horiuchi K; Kano K; Minoshima A; Hayasaka T; Yamauchi A; Tatsukawa T; Matsuo R; Yoshida Y; Tomita Y; Kabara M; Nakagawa N; Takehara N; Hasebe N; Kawabe JI
Am J Physiol Heart Circ Physiol; 2021 Jun; 320(6):H2438-H2447. PubMed ID: 33961504
[TBL] [Abstract][Full Text] [Related]
24. Low vasa vasorum densities correlate with inflammation and subintimal thickening: potential role in location--determination of atherogenesis.
Gössl M; Versari D; Lerman LO; Chade AR; Beighley PE; Erbel R; Ritman EL
Atherosclerosis; 2009 Oct; 206(2):362-8. PubMed ID: 19368925
[TBL] [Abstract][Full Text] [Related]
25. Vasa vasorum hypoxia: initiation of atherosclerosis.
Järvilehto M; Tuohimaa P
Med Hypotheses; 2009 Jul; 73(1):40-1. PubMed ID: 19264413
[TBL] [Abstract][Full Text] [Related]
26. Preclinical restenosis models: challenges and successes.
Touchard AG; Schwartz RS
Toxicol Pathol; 2006; 34(1):11-8. PubMed ID: 16507539
[TBL] [Abstract][Full Text] [Related]
27. Adventitial dysfunction: an evolutionary model for understanding atherosclerosis.
Yun AJ; Doux JD; Bazar KA; Lee PY
Med Hypotheses; 2005; 65(5):962-5. PubMed ID: 16117998
[TBL] [Abstract][Full Text] [Related]
28. Characterization of a new double-injury restenosis model in the rat aorta.
Jahnke T; Karbe U; Schäfer FK; Bolte H; Heuer G; Rector L; Brossmann J; Heller M; Müller-Hülsbeck S
J Endovasc Ther; 2005 Jun; 12(3):318-31. PubMed ID: 15943507
[TBL] [Abstract][Full Text] [Related]
29. Local gene transfer of phVEGF-2 plasmid by gene-eluting stents: an alternative strategy for inhibition of restenosis.
Walter DH; Cejna M; Diaz-Sandoval L; Willis S; Kirkwood L; Stratford PW; Tietz AB; Kirchmair R; Silver M; Curry C; Wecker A; Yoon YS; Heidenreich R; Hanley A; Kearney M; Tio FO; Kuenzler P; Isner JM; Losordo DW
Circulation; 2004 Jul; 110(1):36-45. PubMed ID: 15210598
[TBL] [Abstract][Full Text] [Related]
30. Intimal vascularization and atherosclerosis.
GEIRINGER E
J Pathol Bacteriol; 1951 Apr; 63(2):201-11. PubMed ID: 14851161
[No Abstract] [Full Text] [Related]
31. A model of primary atherosclerosis and post-angioplasty restenosis in mice.
Leidenfrost JE; Khan MF; Boc KP; Villa BR; Collins ET; Parks WC; Abendschein DR; Choi ET
Am J Pathol; 2003 Aug; 163(2):773-8. PubMed ID: 12875996
[TBL] [Abstract][Full Text] [Related]
32. Regulation of angiogenesis by hypoxia: role of the HIF system.
Pugh CW; Ratcliffe PJ
Nat Med; 2003 Jun; 9(6):677-84. PubMed ID: 12778166
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis.
Moulton KS; Vakili K; Zurakowski D; Soliman M; Butterfield C; Sylvin E; Lo KM; Gillies S; Javaherian K; Folkman J
Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4736-41. PubMed ID: 12682294
[TBL] [Abstract][Full Text] [Related]
34. Chronic antioxidant supplementation attenuates nuclear factor-kappa B activation and preserves endothelial function in hypercholesterolemic pigs.
Rodriguez-Porcel M; Lerman LO; Holmes DR; Richardson D; Napoli C; Lerman A
Cardiovasc Res; 2002 Mar; 53(4):1010-8. PubMed ID: 11922911
[TBL] [Abstract][Full Text] [Related]
35. Living the dream of no restenosis.
Teirstein PS
Circulation; 2001 Oct; 104(17):1996-8. PubMed ID: 11673334
[No Abstract] [Full Text] [Related]
36. ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)-executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and Interventions.
Smith SC; Dove JT; Jacobs AK; Kennedy JW; Kereiakes D; Kern MJ; Kuntz RE; Popma JJ; Schaff HV; Williams DO; Gibbons RJ; Alpert JP; Eagle KA; Faxon DP; Fuster V; Gardner TJ; Gregoratos G; Russell RO; Smith SC; ;
Circulation; 2001 Jun; 103(24):3019-41. PubMed ID: 11413094
[No Abstract] [Full Text] [Related]
37. Vascular endothelial growth factor enhances atherosclerotic plaque progression.
Celletti FL; Waugh JM; Amabile PG; Brendolan A; Hilfiker PR; Dake MD
Nat Med; 2001 Apr; 7(4):425-9. PubMed ID: 11283668
[TBL] [Abstract][Full Text] [Related]
38. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice.
Moulton KS; Heller E; Konerding MA; Flynn E; Palinski W; Folkman J
Circulation; 1999 Apr; 99(13):1726-32. PubMed ID: 10190883
[TBL] [Abstract][Full Text] [Related]
39. Adventitial vasa vasorum in balloon-injured coronary arteries: visualization and quantitation by a microscopic three-dimensional computed tomography technique.
Kwon HM; Sangiorgi G; Ritman EL; Lerman A; McKenna C; Virmani R; Edwards WD; Holmes DR; Schwartz RS
J Am Coll Cardiol; 1998 Dec; 32(7):2072-9. PubMed ID: 9857895
[TBL] [Abstract][Full Text] [Related]
40. Arterial remodeling after experimental percutaneous injury is highly dependent on adventitial injury and histopathology.
Staab ME; Srivatsa SS; Lerman A; Sangiorgi G; Jeong MH; Edwards WD; Holmes DR; Schwartz RS
Int J Cardiol; 1997 Jan; 58(1):31-40. PubMed ID: 9021425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
